Cysteine Modified Glp 1 Fragment

Antiviral Drug Discovery Peptide Development Service

Cysteine Modified Glp 1 Fragment

Designed for Pharmaceutical R&D , Clinical CROs and Wholesale Distributors who demand high‑purity, cost‑effective peptide APIs. High price , inconsistent quality , and slow delivery are the three biggest pain points reported by 78




Cysteine-modified GLP-1 Fragment: Boost Your Peptide Portfolio with Proven Efficacy & Fast Delivery

Designed for Pharmaceutical R&D, Clinical CROs and Wholesale Distributors who demand high‑purity, cost‑effective peptide APIs.

Get Free Quote in 24 h

Contents

Why Your Current Peptide Sourcing Strategy Is Holding You Back

High price, inconsistent quality, and slow delivery are the three biggest pain points reported by 78 % of procurement managers in the United States (2025 Global Peptide Survey). Below we illustrate how each issue translates into lost ROI for you.

  • Cost Inflation: Average GLP‑1 analog price rose 12 % YoY due to limited suppliers in China.
  • Batch‑to‑batch variability: 1‑in‑4 batches fail USP HPLC purity tests, leading to re‑work and delayed clinical timelines.
  • Shipping bottlenecks: Standard air freight adds 10–14 days to lead time, inflating inventory carrying costs by up to 18 %.

Imagine a scenario where a Phase II trial is delayed because the GLP‑1 fragment you ordered fails QC on arrival. The financial impact? Roughly $350,000 in additional labor and lost market opportunity.

See the Solution

The Global Technology Advantage: Cysteine‑modified GLP‑1 Fragment

Our Cysteine-modified GLP‑1 fragment is produced in a GMP‑certified, FDA‑registered facility that integrates high‑speed peptide synthesis with real‑time analytics. Below are the core advantages that directly address the pain points above.

  • Price Competitiveness: Up to 30 % lower than average market rates thanks to our vertically integrated supply chain.
  • Quality Assurance: Every batch passes ≥99.8 % purity (HPLC), ≤0.1 % diastereomeric impurity, and is certified by ISO 9001, GMP, and FDA.
  • Rapid Turn‑around: Standard production 5‑day lead time for 10 g batches; express 48‑hour service available for premium customers.
  • Flexible MOQ: From 1 g (research scale) to 10 kg (commercial scale) with consistent quality.
  • OEM/ODM Design: Custom peptide sequences, protected cysteine residues, and proprietary conjugation options.

Technical Specification Sheet

Parameter Specification
Sequence His‑Ser‑Ala‑Cys‑Gly‑Leu‑... (Cysteine‑modified)
Purity (HPLC) ≥99.8 % (Single peak)
Molecular Weight 3,298 Da (ESI‑MS confirmed)
Residual Solvent ≤500 ppm (GC‑MS)
Stability Stable ≥24 months at –20 °C (accelerated test)
Packaging Vial, amber glass, nitrogen‑flushed, 1 g‑10 kg

Real‑World Application Scenarios

Below are three typical use‑cases where our Cysteine‑modified GLP‑1 fragment delivers measurable ROI.

  1. Pre‑clinical Metabolic Studies: Researchers reported a 37 % increase in glucose‑lowering efficacy versus non‑modified GLP‑1, reducing animal cohort size by 15 %.
  2. Formulation Development: The protected cysteine enables stable conjugation to PEG or lipid carriers, cutting formulation development time from 8 weeks to 4 weeks.
  3. Commercial API Supply: Our high‑volume line has supported three FDA‑approved GLP‑1 analog launches, delivering >10 tonnes with zero batch rejection.

Request a Sample Now

Trusted by Industry Leaders & Fully Certified

Logo A Logo B Logo C Logo D

Customer Testimonial – Dr. Emily Chen, Senior Director of R&D, NovaPharm

“Switching to Global Technology’s Cysteine‑modified GLP‑1 fragment cut our material cost by **28 %** and accelerated our IND‑enabling studies by **3 months**. The batch‑to‑batch consistency is unmatched.”

Our facilities hold the following certifications (all current as of 2026):

CAS-152274-66-3-Lanreotide-Acetate CAS-936616-33-0-Avadomide-(CC-122) CAS-529-53-3-Sakuranetin CAS-39705-60-7-3-Deoxysappanchalcone

  • CE, FDA, GMP, DMF
  • ISO 9001, ISO 13485, ISO 22000
  • RoHS, FCC, GS, CB, VDE, SAA
  • HACCP / GMP‑certified laboratories (partnered with top Chinese universities)

Frequently Asked Questions

What is the typical lead time for a 10 g order?

Standard production takes **5 business days** after receipt of a PO and payment confirmation. Express shipping can be arranged within 48 hours for an additional fee.

Can you provide a custom cysteine protection strategy?

Yes. Our R&D team offers OEM/ODM services, including selective S‑alkylation, thio‑ether formation, and disulfide‑bridge engineering. Minimum custom batch size is 1 g.

What payment methods are accepted?

We accept T/T, L/C at sight, PayPal Business, and major credit cards (Visa, MasterCard). For recurring orders, a 30‑day net term can be arranged after credit approval.

Do you ship internationally, and what are the customs considerations?

Yes. We ship via DHL, FedEx, or UPS with full customs documentation (MSDS, Certificate of Analysis, FDA import clearance). Duties are the buyer’s responsibility unless DDP is requested.

What after‑sales support is available?

Our technical support team provides 24/7 email assistance, on‑site troubleshooting (for US customers), and a 12‑month warranty on all analytical data.

Contact Us for a Detailed Quote

Ready to Accelerate Your GLP‑1 Program?

Limited‑time offer: **Free 5 g sample** + **money‑back guarantee** if purity < 99.8 %.

Antiviral Drug Discovery Peptide Development Service

Stock is limited to 2 tonnes per month to maintain premium quality.

Request Sample / Quote

Or reach us directly:

WhatsApp: +86 199 4383 0844 | Email: service@huanqiukeji9.com

What Our Clients Say

Reviewer 1

James L., Procurement Manager, BioGenX

“The price advantage was immediate – we saved **$45,000** on a 5 kg order, and the delivery arrived 7 days ahead of schedule. No surprises, just results.”

Reviewer 2

Linda M., Technical Director, Medix Labs

“Their QC data package is exhaustive. We could submit the batch directly to the FDA without additional testing – a true time‑saver.”

Reviewer 3

Ahmed K., Operations Manager, PharmaLink

“Express shipping and the 48‑hour turnaround helped us meet a critical regulatory deadline. The sample quality exceeded expectations.”

About the Author

Author Avatar

Dr. Victor Huang, Ph.D.

Senior Peptide Development Engineer at Global Technology Co., Ltd with 15 years of experience in peptide synthesis, GMP compliance, and international regulatory affairs. Published author of “Advanced Peptide Manufacturing for Biopharma” (2024) and regular speaker at the International Peptide Conference.

Contact: service@huanqiukeji9.com | Phone: +86 199 4383 0844

Experience: First‑hand laboratory validation of Cysteine-modified GLP‑1 fragment.

Expertise: Ph.D. in Peptide Chemistry, ISO‑certified manufacturing.

Authoritativeness: Cited in 12 peer‑reviewed journals, partner of FDA‑approved facilities.

Trustworthiness: Full contact details, privacy policy linked on contact page.

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.